Format

Send to

Choose Destination
Hepatogastroenterology. 2000 Sep-Oct;47(35):1216-20.

Alterations of retinoblastoma protein and p16INK4 protein expression in extrahepatic bile duct carcinomas.

Author information

1
Department of Surgery, Graduate School of Medicine, University of Tokyo, Japan.

Abstract

BACKGROUND/AIMS:

Human cancer development results from dysfunction of G1-phase regulators of the cell cycle. Retinoblastoma protein and p16INK4 are the most essential links between cell cycle control and cancer. We examined the expression of p16INK4 and pRb and their possible prognostic relevance in 34 extrahepatic bile duct carcinomas.

METHODOLOGY:

Expression of pRb and p16INK4 was determined using immunohistochemical techniques. Associations between expression of pRb and p16INK4 and the clinicopathological features were analyzed by using the chi 2 test and survival analysis was performed by Log-rank test.

RESULTS:

Two (6%) extrahepatic bile duct carcinomas were pRb negative, 26 (76%) showed pRb overexpression, and 6 (18%) demonstrated moderate expression. Twenty-two (65%) tumors were p16INK4 negative and 12 (35%) were p16INK4-positive. Cases with pRb-negative or pRb overexpression were significantly correlated with tumor progression (P = 0.004) and TNM stage (P = 0.009). Alterations in pRb and p16INK4 expression did not correlate with patient outcome.

CONCLUSIONS:

Alterations of pRb and p16INK4 expression are frequently involved in extrahepatic bile duct carcinomas, and that aberrant pRb expression significantly associates with tumor progression.

PMID:
11100316
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center